The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
Open accessAbstract
Immune evasion and metabolic reprogramming are two fundamental hallmarks of cancer. Interestingly, lactate closely links them together. However, lactate has long been recognized as a metabolic waste product. Lactate and the acidification of the tumor microenvironment (TME) promote key carcinogenesis processes, including angiogenesis, invasion, metastasis, and immune escape. Notably, histone lysine lactylation (Kla) was identified as a novel post-modification (PTM), providing a new perspective on the mechanism by which lactate functions and providing a promising and potential therapy for tumors target. Further studies have confirmed that protein lactylation is essential for lactate to function; it involves important life activities such as glycolysis-related cell functions and macrophage polarization. This review systematically elucidates the role of lactate as an immunosuppressive molecule from the aspects of lactate metabolism and the effects of histone lysine or non-histone lactylation on immune cells; it provides new ideas for further understanding protein lactylation in elucidating lactate regulation of cell metabolism and immune function. We explored the possibility of targeting potential targets in lactate metabolism for cancer treatment. Finally, it is promising to propose a combined strategy inhibiting the glycolytic pathway and immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“An important feature of energy metabolism in tumor cells is known as the “Warburg effect” [6]; it is reported that cancer cells prefer to consume large amounts of glucose through glycolysis rather than favor oxidative phosphorylation, even in a sufficient supply of oxygen; it has been thought that only cancer cells co…”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 4×
“[10] identified that lipopolysaccharide (LPS)-activated M1 macrophages enhanced glycolytic metabolism and increased lactate concentration.”
BackgroundInfluentialMetabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 2×
“Moreover, tumor-derived lactate can induce tumor-associated macrophage (TAM) polarization to the M2 immunosuppressive phenotype by binding to the lactate-sensitive receptor-G proteincoupled receptor 132(GPR132) [57,58].”
BackgroundTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Kelly, B., & O'Neill, L. A. (2015) · Cell Research · doi:10.1038/cr.2015.68 · Cited by 1,876 · cited 1×
“predominantly myeloid cells, also do [7,8].”
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624
A decade of immune-checkpoint inhibitors in cancer therapy
Robert, C. (2020) · Nature Communications · doi:10.1038/s41467-020-17670-y · Cited by 1,608
Hodi, F. S., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Cowey, C. L., Lao, C. D., Schadendorf, D., Wagstaff, J., Dummer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30700-9 · Cited by 1,399 · cited 1×
“LDH levels in blood and TME correlate with poor prognosis in cancer patients and can be used to determine tumor staging in melanoma [96].”
BackgroundPalsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397 · cited 7×
“Similarly, lactate-mediated activation of G protein-coupled receptor 81(GPR81), G protein-coupled cell surface lactate receptor, in DCs was found to abolish antigen presentation, secretion of proinflammatory cytokines IL-6 and IL-12, and T cell function and promotes tumor progression in a mouse model [52].”
BackgroundInfluentialMetabolic support of tumour-infiltrating regulatory T cells by lactic acid
Watson, M. J., Vignali, P. D. A., Mullett, S. J., Overacre-Delgoffe, A. E., Peralta, R. M., Grebinoski, S., Menk, A. V., Rittenhouse, N. L., DePeaux, K., Whetstone, R. D., et al. (2021) · Nature · doi:10.1038/s41586-020-03045-2 · Cited by 1,259
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil-de-Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,246
Lactate: the ugly duckling of energy metabolism
Rabinowitz, J. D., & Enerbäck, S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0243-4 · Cited by 1,049
Cell-programmed nutrient partitioning in the tumour microenvironment
Reinfeld, B. I., Madden, M. Z., Wolf, M. M., Chytil, A., Bader, J. E., Patterson, A. R., Sugiura, A., Cohen, A. S., Ali, A., Do, B. T., et al. (2021) · Nature · doi:10.1038/s41586-021-03442-1 · Cited by 1,023
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J. G., Yu, Z., Roychoudhuri, R., Palmer, D. C., Muranski, P., Karoly, E. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69589 · Cited by 952 · cited 1×
“Multiple studies have shown that drugs targeting tumor aerobic glycolysis inhibit T cell function and promote immunosuppression [112].”
BackgroundYu, J., Chai, P., Xie, M., Ge, S., Ruan, J., Fan, X., & Jia, R. (2021) · Genome Biology · doi:10.1186/s13059-021-02308-z · Cited by 940
Kumagai, S., Koyama, S., Itahashi, K., Tanegashima, T., Lin, Y.-T., Togashi, Y., Kamada, T., Irie, T., Okumura, G., Kono, H., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.01.001 · Cited by 892
Martinez, M., & Moon, E. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00128 · Cited by 851
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 850
Xiong, J., He, J., Zhu, J., Pan, J., Liao, W., Ye, H., Wang, H., Song, Y., Du, Y., Cui, B., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.033 · Cited by 804
Yang, K., Fan, M., Wang, X., Xu, J., Wang, Y., Tu, F., Gill, P. S., Ha, T., Liu, L., Williams, D. L., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-021-00841-9 · Cited by 798
Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Peng, M., Yin, N., Chhangawala, S., Xu, K., Leslie, C. S., & Li, M. O. (2016) · Science · doi:10.1126/science.aaf6284 · Cited by 787
Haas, R., Smith, J., Rocher-Ros, V., Nadkarni, S., Montero-Melendez, T., D’Acquisto, F., Bland, E. J., Bombardieri, M., Pitzalis, C., Perretti, M., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002202 · Cited by 774
The future of cancer immunotherapy: microenvironment-targeting combinations
Murciano-Goroff, Y. R., Warner, A. B., & Wolchok, J. D. (2020) · Cell Research · doi:10.1038/s41422-020-0337-2 · Cited by 749
The monocarboxylate transporter family—Role and regulation
Halestrap, A. P., & Wilson, M. C. (2012) · IUBMB Life · doi:10.1002/iub.572 · Cited by 741
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., & Kreutz, M. (2006) · Blood · doi:10.1182/blood-2005-05-1795 · Cited by 729
Lactate as a fulcrum of metabolism
Brooks, G. A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101454 · Cited by 724
Monocarboxylate transporters in cancer
Payen, V. L., Mina, E., Van Hée, V. F., Porporato, P. E., & Sonveaux, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.006 · Cited by 644
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Cascone, T., McKenzie, J. A., Mbofung, R. M., Punt, S., Wang, Z., Xu, C., Williams, L. J., Wang, Z., Bristow, C. A., Carugo, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.024 · Cited by 611
Self-citationNeutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Pilon-Thomas, S., Kodumudi, K. N., El-Kenawi, A. E., Russell, S., Weber, A. M., Luddy, K., Damaghi, M., Wojtkowiak, J. W., Mulé, J. J., Ibrahim-Hashim, A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1743 · Cited by 593
Brizel, D. M., Schroeder, T., Scher, R. L., Walenta, S., Clough, R. W., Dewhirst, M. W., & Mueller-Klieser, W. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01630-3 · Cited by 586
Pucino, V., Certo, M., Bulusu, V., Cucchi, D., Goldmann, K., Pontarini, E., Haas, R., Smith, J., Headland, S. E., Blighe, K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.004 · Cited by 530
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Scharping, N. E., Menk, A. V., Whetstone, R. D., Zeng, X., & Delgoffe, G. M. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0103 · Cited by 520 · cited 1×
“A combination of Metformin with anti-PD-1 improves T-cell function and tumor clearance in mice with melanoma [101].”
BackgroundGpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis
Chen, P., Zuo, H., Xiong, H., Kolar, M. J., Chu, Q., Saghatelian, A., Siegwart, D. J., & Wan, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614035114 · Cited by 520
Ordered Cooperative Functions of PRMT1, p300, and CARM1 in Transcriptional Activation by p53
An, W., Kim, J., & Roeder, R. G. (2004) · Cell · doi:10.1016/j.cell.2004.05.009 · Cited by 511
NK Cell Metabolism and Tumor Microenvironment
Terrén, I., Orrantia, A., Vitallé, J., Zenarruzabeitia, O., & Borrego, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02278 · Cited by 501
Gu, J., Zhou, J., Chen, Q., Xu, X., Gao, J., Li, X., Shao, Q., Zhou, B., Zhou, H., Wei, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110986 · Cited by 490
Brown, T. P., & Ganapathy, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107451 · Cited by 481
Irizarry-Caro, R. A., McDaniel, M. M., Overcast, G. R., Jain, V. G., Troutman, T. D., & Pasare, C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009778117 · Cited by 457
Chen, W., Liang, X., Peterson, A. J., Munn, D. H., & Blazar, B. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5396 · Cited by 453
Li, W., Tanikawa, T., Kryczek, I., Xia, H., Li, G., Wu, K., Wei, S., Zhao, L., Vatan, L., Wen, B., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.022 · Cited by 446
Effect of tumor cells and tumor microenvironment on NK‐cell function
Vitale, M., Cantoni, C., Pietra, G., Mingari, M. C., & Moretta, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344272 · Cited by 412
Non-enzymatic Lysine Lactoylation of Glycolytic Enzymes
Gaffney, D. O., Jennings, E. Q., Anderson, C. C., Marentette, J. O., Shi, T., Schou Oxvig, A.-M., Streeter, M. D., Johannsen, M., Spiegel, D. A., Chapman, E., et al. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.11.005 · Cited by 410
Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes
Dietl, K., Renner, K., Dettmer, K., Timischl, B., Eberhart, K., Dorn, C., Hellerbrand, C., Kastenberger, M., Kunz-Schughart, L. A., Oefner, P. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902584 · Cited by 401
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
Zappasodi, R., Serganova, I., Cohen, I. J., Maeda, M., Shindo, M., Senbabaoglu, Y., Watson, M. J., Leftin, A., Maniyar, R., Verma, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03326-4 · Cited by 393
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
Tang, J., Yu, J. X., Hubbard-Lucey, V. M., Neftelinov, S. T., Hodge, J. P., & Lin, Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.210 · Cited by 382
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 374
Karve, T. M., & Cheema, A. K. (2011) · Journal of Amino Acids · doi:10.4061/2011/207691 · Cited by 364
Lactate Limits T Cell Proliferation via the NAD(H) Redox State
Quinn, W. J., Jiao, J., TeSlaa, T., Stadanlick, J., Wang, Z., Wang, L., Akimova, T., Angelin, A., Schäfer, P. M., Cully, M. D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108500 · Cited by 362
Harmon, C., Robinson, M. W., Hand, F., Almuaili, D., Mentor, K., Houlihan, D. D., Hoti, E., Lynch, L., Geoghegan, J., & O'Farrelly, C. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0481 · Cited by 360
Seo, J.-W., & Lee, K.-J. (2004) · BMB Reports · doi:10.5483/bmbrep.2004.37.1.035 · Cited by 358
Wang, F., Wang, K., Xu, W., Zhao, S., Ye, D., Wang, Y., Xu, Y., Zhou, L., Chu, Y., Zhang, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.065 · Cited by 340
Latham, T., Mackay, L., Sproul, D., Karim, M., Culley, J., Harrison, D. J., Hayward, L., Langridge-Smith, P., Gilbert, N., & Ramsahoye, B. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks066 · Cited by 333
Cell Surface Lactate Receptor GPR81 Is Crucial for Cancer Cell Survival
Roland, C. L., Arumugam, T., Deng, D., Liu, S. H., Philip, B., Gomez, S., Burns, W. R., Ramachandran, V., Wang, H., Cruz-Monserrate, Z., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0319 · Cited by 327
Wilde, L., Roche, M., Domingo-Vidal, M., Tanson, K., Philp, N., Curry, J., & Martinez-Outschoorn, U. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.10.004 · Cited by 326
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation
Mendler, A. N., Hu, B., Prinz, P. U., Kreutz, M., Gottfried, E., & Noessner, E. (2012) · International Journal of Cancer · doi:10.1002/ijc.26410 · Cited by 319
Glis1 facilitates induction of pluripotency via an epigenome–metabolome–epigenome signalling cascade
Li, L., Chen, K., Wang, T., Wu, Y., Xing, G., Chen, M., Hao, Z., Zhang, C., Zhang, J., Ma, B., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0267-9 · Cited by 315
Brown, T. P., Bhattacharjee, P., Ramachandran, S., Sivaprakasam, S., Ristic, B., Sikder, M. O. F., & Ganapathy, V. (2020) · Oncogene · doi:10.1038/s41388-020-1216-5 · Cited by 304
Yang, K., Xu, J., Fan, M., Tu, F., Wang, X., Ha, T., Williams, D. L., & Li, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587913 · Cited by 301
Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments
Draoui, N., & Feron, O. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007724 · Cited by 296
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway
Shime, H., Yabu, M., Akazawa, T., Kodama, K., Matsumoto, M., Seya, T., & Inoue, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7175 · Cited by 285
Comito, G., Iscaro, A., Bacci, M., Morandi, A., Ippolito, L., Parri, M., Montagnani, I., Raspollini, M. R., Serni, S., Simeoni, L., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0688-7 · Cited by 241
Targeting natural killer cells in solid tumors
Habif, G., Crinier, A., André, P., Vivier, E., & Narni-Mancinelli, E. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0224-2 · Cited by 241
Santoni, M., Romagnoli, E., Saladino, T., Foghini, L., Guarino, S., Capponi, M., Giannini, M., Cognigni, P. D., Ferrara, G., & Battelli, N. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.10.007 · Cited by 237
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy
Wang, H., Franco, F., & Ho, P.-C. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.06.005 · Cited by 234
Metabolic regulation of chromatin modifications and gene expression
Schvartzman, J. M., Thompson, C. B., & Finley, L. W. S. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201803061 · Cited by 233
Dendritic Cell Reprogramming by Endogenously Produced Lactic Acid
Nasi, A., Fekete, T., Krishnamurthy, A., Snowden, S., Rajnavölgyi, E., Catrina, A. I., Wheelock, C. E., Vivar, N., & Rethi, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300772 · Cited by 189
Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response
Cassim, S., & Pouyssegur, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010157 · Cited by 188
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells
Raychaudhuri, D., Bhattacharya, R., Sinha, B. P., Liu, C. S. C., Ghosh, A. R., Rahaman, O., Bandopadhyay, P., Sarif, J., D'Rozario, R., Paul, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01878 · Cited by 176
Bhagat, T. D., Von Ahrens, D., Dawlaty, M., Zou, Y., Baddour, J., Achreja, A., Zhao, H., Yang, L., Patel, B., Kwak, C., et al. (2019) · eLife · doi:10.7554/elife.50663 · Cited by 173
Microbial carcinogenesis: Lactic acid bacteria in gastric cancer
Vinasco, K., Mitchell, H. M., Kaakoush, N. O., & Castaño-Rodríguez, N. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.07.004 · Cited by 171
Microenvironmental Metabolism Regulates Antitumor Immunity
Ngwa, V. M., Edwards, D. N., Philip, M., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0617 · Cited by 171
Histone Lactylation: A New Role for Glucose Metabolism
Liberti, M. V., & Locasale, J. W. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.12.004 · Cited by 169
Daneshmandi, S., Wegiel, B., & Seth, P. (2019) · Cancers · doi:10.3390/cancers11040450 · Cited by 167
Xia, H., Wang, W., Crespo, J., Kryczek, I., Li, W., Wei, S., Bian, Z., Maj, T., He, M., Liu, J. R., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan4631 · Cited by 162
Fang, Y., Liu, W., Tang, Z., Ji, X., Zhou, Y., Song, S., Tian, M., Tao, C., Huang, R., Zhu, G., et al. (2023) · Hepatology · doi:10.1002/hep.32348 · Cited by 162
Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology
Husain, Z., Seth, P., & Sukhatme, V. (2013) · OncoImmunology · doi:10.4161/onci.26383 · Cited by 161
T-cells produce acidic niches in lymph nodes to suppress their own effector functions
Wu, H., Estrella, V., Beatty, M., Abrahams, D., El-Kenawi, A., Russell, S., Ibrahim-Hashim, A., Longo, D. L., Reshetnyak, Y. K., Moshnikova, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17756-7 · Cited by 159
Ganapathy‐Kanniappan, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.04.002 · Cited by 157
Kouidhi, S., Elgaaïed, A. B., & Chouaïb, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00270 · Cited by 152
Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors
Kes, M. M. G., den Bossche, J. V., Griffioen, A. W., & Huijbers, E. J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188427 · Cited by 152
Beloueche‐Babari, M., Galobart, T. C., Delgado‐Goñi, T., Wantuch, S., Parkes, H. G., Tandy, D., Harker, J. A., & Leach, M. O. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0717-x · Cited by 148
Systematic Analysis of Lysine Lactylation in the Plant Fungal Pathogen Botrytis cinerea
Gao, M., Zhang, N., & Liang, W. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.594743 · Cited by 145
PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension
Kovács, L., Cao, Y., Han, W., Meadows, L., Kovács‐Kása, A., Kondrikov, D., Verin, A. D., Barman, S. A., Dong, Z., Huo, Y., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201812-2290oc · Cited by 143
Connections Between Metabolism and Epigenetics in Programming Cellular Differentiation
Chisolm, D. A., & Weinmann, A. S. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053127 · Cited by 134
Lactic acid delays the inflammatory response of human monocytes
Peter, K., Rehli, M., Singer, K., Renner, K., & Kreutz, M. P. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.005 · Cited by 132
Pötzl, J., Roser, D., Bankel, L., Hömberg, N., Geishauser, A., Brenner, C. D., Weigand, M., Röcken, M., & Mocikat, R. (2017) · International Journal of Cancer · doi:10.1002/ijc.30646 · Cited by 122
Cutting Edge: Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses
Bajwa, G., DeBerardinis, R. J., Shao, B., Hall, B. E., Farrar, J. D., & Gill, M. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501557 · Cited by 116
A "Lactatic" Perspective on Metabolism
Gladden, L. B. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31815fa580 · Cited by 114
Metabolic Influences That Regulate Dendritic Cell Function in Tumors
Dong, H., & Bullock, T. N. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00024 · Cited by 96
Afzal, M. Z., Dragnev, K. H., Sarwar, T., & Shirai, K. (2019) · Lung Cancer Management · doi:10.2217/lmt-2018-0016 · Cited by 96
Lactate transporters as therapeutic targets in cancer and inflammatory diseases
Pucino, V., Cucchi, D., & Mauro, C. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1511706 · Cited by 90
Petrelli, F., Ardito, R., Merelli, B., Lonati, V., Cabiddu, M., Seghezzi, S., Barni, S., & Ghidini, A. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000520 · Cited by 90
Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s
Wagner, M., Ealey, K. N., Tetsu, H., Kiniwa, T., Motomura, Y., Moro, K., & Koyasu, S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.103 · Cited by 86
Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer
Tu, V. Y., Ayari, A., & O’Connor, R. S. (2021) · Antibodies · doi:10.3390/antib10030025 · Cited by 85
Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response
Xiao, Q., Nobre, A., Piñeiro, P., Berciano‐Guerrero, M., Alba, E., Cobo, M., Lauschke, V. M., & Barragán, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010286 · Cited by 83
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma
Choi, J.-E., Sebastián, C., Ferrer, C. M., Lewis, C. A., Sade-Feldman, M., LaSalle, T. J., Gonye, A. L. K., Lopez, B. G. C., Abdelmoula, W. M., Regan, M. S., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00350-6 · Cited by 52
An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines
Ott, P. A., Dotti, G., Yee, C., & Goff, S. L. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238001 · Cited by 51
Sharma, N. K., & Pal, J. K. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200521075252 · Cited by 41
Plastic Heterogeneity of Innate Lymphoid Cells in Cancer
Wagner, M., Moro, K., & Koyasu, S. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.03.008 · Cited by 37
Integrative Proteomic Analysis of Multiple Posttranslational Modifications in Inflammatory Response
Ji, F., Zhou, M., Zhu, H., Jiang, Z., Li, Q., Ouyang, X., Lv, Y., Zhang, S., Wu, T., & Li, L. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.11.004 · Cited by 37
Larkin, J., Chiarion‐Sileni, V., González, R., Grob, J., Cowey, C. L., Lao, C. D., Wagstaff, J., Hogg, D., Hill, A., Carlino, M. S., et al. (2015) · European Journal of Cancer · doi:10.1016/s0959-8049(16)31822-6 · Cited by 36
Linking Immunoevasion and Metabolic Reprogramming in B-Cell–Derived Lymphomas
Böttcher, M., Baur, R., Stoll, A., Mackensen, A., & Mougiakakos, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.594782 · Cited by 36
Crosstalk between cellular metabolism and histone acetylation
Trefely, S., Doan, M. T., & Snyder, N. W. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.013 · Cited by 31
Does Baking Soda Function as a Magic Bullet for Patients With Cancer? A Mini Review
Yang, M., Zhong, X., & Yuan, Y. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735420922579 · Cited by 29
Degauque, N., Brosseau, C., & Brouard, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01465 · Cited by 25
Epigenetic regulation by endogenous metabolite pharmacology
Kulkarni, R. A., Montgomery, D. C., & Meier, J. L. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.02.002 · Cited by 25
Cited by
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
Muscle-derived small extracellular vesicles induce liver fibrosis during overtraining
Liu, Y., Zhou, R., Guo, Y., Hu, B., Xie, L., An, Y., Wen, J., Liu, Z., Zhou, M., Kuang, W., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2024.12.005 · Cited by 78
Metabolic reprogramming: The driving force behind cancer drug resistance
El-Sehrawy, A. A. M. A., Hsu, C.-Y., Alkhathami, A. G., Chandra, M., Basunduwah, T. S., Malathi, H., Senapati, J. N., Gautam, A., Kadhem, M., & Yasin, H. A. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152392 · Cited by 11
Metadata
- Authors
- Chen, L., Huang, L., Gu, Y., Cang, W., Sun, P., & Xiang, Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-10-08
- Volume
- 23
- Issue
- 19
- Pages
- 11943
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4303709971
- Cited by
- 344
- References
- 111
- FWCI
- 21.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.